Company: LNAI
Filing Date: 2025-08-06
Form Type: 8-K
Source: 0001731122-25-001076
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-08-06
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing
Rule or Standard; Transfer of Listing.

On July 7, 2025, Renovaro Inc. (the “ Company”) received a notice
from The Nasdaq Stock Market LLC (“ Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a),
which requires listed companies to hold an annual meeting of shareholders within twelve months of the end of their fiscal year.

On August 5, 2025, the Company received written confirmation from Nasdaq
that it has accepted the Company’s plan to regain compliance and has granted an extension until October 31, 2025, for the Company
to hold its annual meeting of shareholders.

The Company intends to hold the annual meeting within the extension period
to regain compliance with the Rule.

Forward-Looking Statements